Anti-Ageing Stack

These three peptides create a powerful anti-ageing synergy by targeting distinct but complementary pathways. GHK-Cu works primarily through copper-dependent enzymatic processes, stimulating collagen and elastin production whilst reducing inflammation. Studies demonstrate its ability to improve skin thickness, reduce fine lines, and accelerate wound healing through enhanced protein synthesis.

Epithalon operates at the genetic level, with research suggesting it activates telomerase enzyme activity, potentially slowing chromosomal ageing. Additionally, it influences the pineal gland, supporting melatonin production and circadian rhythm regulation. This dual action addresses both cellular ageing and sleep quality—crucial for recovery and longevity.

MOTS-c targets the cellular powerhouses: mitochondria. Early evidence indicates it enhances mitochondrial biogenesis, improves insulin sensitivity, and boosts energy metabolism. This mitochondrial support is fundamental to healthy ageing, as mitochondrial dysfunction underlies many age-related declines.

Together, these mechanisms create a comprehensive anti-ageing protocol: GHK-Cu repairs and rebuilds tissues, Epithalon protects genetic material and optimises recovery, whilst MOTS-c ensures efficient cellular energy production. Users often report improvements in skin quality within weeks, enhanced energy levels, and better sleep patterns. The stack addresses both visible signs of ageing and underlying cellular health, making it a popular choice for those seeking evidence-based longevity support.

GHK-Cu Protocol: Reconstitute 50mg vial with 5ml bacteriostatic water for 10mg/ml concentration. Inject 2mg (0.2ml) subcutaneously daily, preferably evening. Rotate injection sites between abdomen and thighs. Cycle: 60 days on, 30 days off. Store reconstituted solution refrigerated for up to 30 days.

Epithalon Protocol: Reconstitute 10mg vial with 2ml bacteriostatic water for 5mg/ml concentration. Inject 10mg (2ml) subcutaneously before bed for 10 consecutive days, then 20 days off. Repeat cycle 2-3 times yearly. Some users prefer splitting into 5mg twice daily. Deep sleep timing maximises pineal gland interaction.

MOTS-c Protocol: Reconstitute 5mg vial with 1ml bacteriostatic water. Inject 5-10mg subcutaneously 2-3 times weekly, ideally 30 minutes before exercise to enhance metabolic benefits. Cycle: 4 weeks on, 2 weeks off. Start with 5mg to assess tolerance.

General Guidelines: Use our reconstitution calculator for precise measurements. Alternate injection sites daily to prevent tissue irritation. Store peptides frozen until use, reconstituted solutions refrigerated. Begin with lower doses to assess individual response. Consider spacing injections throughout the day rather than combining in one injection for optimal absorption. Always use sterile technique and insulin syringes for accurate dosing.

Weeks 1-2: Initial improvements often include better sleep quality (Epithalon effect) and slightly increased energy levels from MOTS-c. Some users notice improved skin hydration from GHK-Cu, though significant changes require time.

Weeks 3-4: More pronounced benefits emerge. Skin texture improvements become visible with GHK-Cu's collagen-stimulating effects. Energy levels stabilise at higher baseline with MOTS-c supporting mitochondrial function. Sleep patterns typically show marked improvement with Epithalon cycles.

Month 2: Cumulative effects become apparent. Skin elasticity and fine line reduction from GHK-Cu are more noticeable. Enhanced exercise capacity and metabolic efficiency from MOTS-c become evident. Overall energy and recovery improve significantly.

Month 3: Peak benefits typically manifest. Users report sustained improvements in skin quality, consistent energy levels, and optimised sleep patterns. The synergistic effects of all three peptides create a comprehensive anti-ageing profile. Results plateau around this timeframe, making it ideal for reassessing dosing protocols.

Individual responses vary considerably based on age, lifestyle, and baseline health. Younger users may notice subtler changes, whilst those over 40 often report more dramatic improvements in energy and skin quality.

GHK-Cu is generally well-tolerated, though some users experience mild injection site reactions or temporary skin sensitivity. Copper accumulation is theoretical concern with extended use, though no documented cases exist at recommended doses.

Epithalon typically produces minimal side effects. Occasional vivid dreams or altered sleep patterns may occur initially as circadian rhythms adjust. Very rare reports of mild headaches during first cycles.

MOTS-c may cause temporary injection site irritation or mild flu-like symptoms in sensitive individuals. Some users report increased appetite as metabolism improves.

Contraindications: Pregnant or breastfeeding women should avoid all peptides. Those with autoimmune conditions should consult healthcare providers before use. Cancer patients or those with history of malignancy should exercise particular caution with growth-promoting peptides like GHK-Cu.

UK Legal Considerations: These peptides exist in a regulatory grey area. Review our UK peptide legality guide for current status. Purchase only from reputable suppliers conducting third-party testing.

When to Discontinue: Stop immediately if experiencing severe allergic reactions, persistent injection site problems, or unexpected symptoms. Begin with conservative doses to assess individual tolerance before progressing to full protocols.